Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration adopted approach B.1 lineage B.1.621 BNT161b2 booster dose Characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccine development Evidence exacerbated Genetic genomic Genomic surveillance global mass vaccination Health implementation infections Intervention Lineage mass vaccination Mu variant mutations Neutralizing non-pharmaceutical interventions (NPIs) NPIs potential risk public health measure public health measures Recombination reported required respiratory restrict SARS-CoV-2 SARS-CoV-2 B.1.621 SARS-CoV-2 virus sera shown Strains Strategy sub-lineage B.1.621.1 Surveillance survivor the SARS-CoV-2 virus therapeutic threat vaccination Vaccine vaccine breakthrough. Vaccine development variant variants [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseasesArticle Published on 2022-10-262022-11-15 Journal: Scientific Reports [Category] 진단, [키워드] antibody antibody unit Autoimmune comparable control group COVID-19 vaccine COVID-19 vaccine development defined dose Efficacy General population HCQ IgG IgG antibodies IgG antibody immunogenic immunogenicity immunomodulatory medications inactivated Inflammatory low dose median MTX no difference Patient patients treated positive serum antibodies Progress Protein reduced rheumatic disease second vaccination Seropositivity serum IgG significantly SLE statistical significance statistically significant suppressed treated [DOI] 10.1038/s41598-022-22839-0 PMC 바로가기
Maternal Attitudes and Intentions About the COVID-19 Vaccine for Children Aged 5-11 Years5-11세 어린이를 위한 COVID-19 백신에 대한 어머니의 태도와 의도Article Published on 2022-09-012022-09-11 Journal: Journal of pediatric health care : official public [Category] COVID19(2023년), SARS, 변종, [키워드] age approval Attitude changed children COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccine development delta variant examined Factors highlight Intention likelihood Maternal MOST mother mothers Odds ratio participant Precaution Qualtrics questionnaire Questionnaires recruited reported the United State United States vaccination Vaccine vaccine. white Year [DOI] 10.1016/j.pedhc.2022.05.015 PMC 바로가기 [Article Type] Article
Communicating about COVID-19 vaccine development and safetyRandomized Controlled Trial Published on 2022-08-052022-10-05 Journal: PLoS ONE [Category] 임상, [키워드] assigned belief Communicating conducted control group COVID-19 COVID-19 mRNA vaccines COVID-19 vaccine COVID-19 vaccine development driver experiment expressed Factor identify IMPROVE Intention Intervention MOST promote Randomly reduce refusal Research risk significantly tested the vaccine vaccination intentions Vaccine vaccine intentions veteran with COVID-19 [DOI] 10.1371/journal.pone.0272426 PMC 바로가기 [Article Type] Randomized Controlled Trial
Leveraging lessons learned from the COVID-19 pandemic for HIV Reviews Published on 2022-08-012022-10-05 Journal: Communications Medicine [Category] 임상, 진단, 치료법, [키워드] accelerated contribute COVID-19 pandemic COVID-19 vaccine COVID-19 vaccine development Government highlight HIV HIV vaccine HIV/AIDS impacted include Inclusion key consideration knowledge less pandemic pathogen Population public health Research Safe [DOI] 10.1038/s43856-022-00175-8 [Article Type] Reviews
A streamlined platform for analyzing tera-scale DDA and DIA mass spectrometry data enables highly sensitive immunopeptidomics테라급 DDA 및 DIA 질량 분석 데이터를 분석하기 위한 간소화된 플랫폼으로 고감도 면역펩티드학 가능Article Published on 2022-06-072022-09-11 Journal: Nature Communications [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] acquisition Analysis approach boost Control COVID-19 vaccine development Data analysis database dataset datasets de novo Epitopes evaluated identify mass spectrometry peptide peptides platform precursor reported SARS-CoV-2 sensitivity Sequencing specificity Support T-cell epitope T-cell epitopes target [DOI] 10.1038/s41467-022-30867-7 PMC 바로가기 [Article Type] Article
Accelerating clinical trial development in vaccinology: COVID-19 and beyondReview article Published on 2022-06-012022-10-05 Journal: Current opinion in immunology [Category] 비임상, 임상, [키워드] accelerated clinical trial COVID-19 COVID-19 vaccine COVID-19 vaccine development criteria Efficacy effort endpoints Government independent lesson offer operation pathogen protocols public health Research Safe speed statistical trials Vaccine vaccine candidate vaccine platform [DOI] 10.1016/j.coi.2022.102206 [Article Type] Review article
The impact of COVID-19 on income and employment and willingness to become vaccinated among African Americans enrolled in a smoking cessation randomized trialRandomized Controlled Trial Published on 2022-03-152022-10-04 Journal: Vaccine [Category] COVID19(2023년), SARS, 임상, [키워드] African African American African Americans approach clinical trial coronavirus COVID COVID-19 COVID-19 vaccine development demonstrated employment enrolled finding Health highlight impacted IMPROVE Intensive MOST Population randomized trial smoker smoking subgroups the vaccine Vaccine Vaccine acceptance Vaccine hesitancy vaccine hesitancy. vaccine-hesitant with COVID-19 [DOI] 10.1016/j.vaccine.2022.01.064 PMC 바로가기 [Article Type] Randomized Controlled Trial
COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity재조합 바이러스 및 박테리아 벡터 시스템을 기반으로 한 COVID-19 백신 개발: 적응 및 훈련된 면역의 조합 효과Review Published on 2022-03-012022-09-11 Journal: Journal of microbiology (Seoul, Korea) [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus adaptive addition Antigen approach approval Bacteria Bacterial bacterial vector vaccine BCG cause cell-mediated immune response coronavirus coronavirus disease Coronavirus disease 2019 country COVID-19 COVID-19 infections COVID-19 pandemic COVID-19 vaccine COVID-19 vaccine development COVID-19 vaccines death Effect Efficacy Heterologous heterologous vaccine humoral immune responses immune responses Immunity induce Infection infections innate immune cell many case many cases memory MMR modulate polio Prevent PROTECT SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Severe acute respiratory syndrome trained immunity Vaccine vaccine candidate vaccine candidates Vaccines variants vector viral system Viral vector vaccine viral vector vaccine. virus [DOI] 10.1007/s12275-022-1621-2 PMC 바로가기 [Article Type] Review
Relationship between lay and expert perceptions of COVID-19 vaccine development timelines in Canada and USAResearch Article Published on 2022-02-152022-10-28 Journal: PLoS ONE [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] aggregate article Canada collected Contact COVID-19 vaccine development demographic variable estimate explained individual level median objective occur participant Probability Qualtrics recruited relationship response Result Sample SARS-CoV-2 vaccine the median timeline USA Vaccine Vaccine development Variation [DOI] 10.1371/journal.pone.0262740 PMC 바로가기 [Article Type] Research Article